Dana-Farber Cancer Institute
N

Relapse Refractory Myeloma and Novel Treatments

By Dana-Farber Cancer Institute FEATURING Noopur S. Raje
By Dana-Farber Cancer Institute FEATURING Noopur S. Raje
246 views
June 22, 2018
Comments 0
Login to view comments. Click here to Login

Featured Video

15:58
Amgen Hematology

Insights on Proteasome Inhibitor Combinations at First Relapse in Mu…

Feat. M. Levy

Related Videos

21:06

ASH 2024 Summary: Myeloma Highlights and Impact on Practice

2024 ASH Annual Meeting Insights Hub

H. Hashmi

1.4K views
28:15

ASH 2024 Review: Key Multiple Myeloma Abstracts

Cleveland Clinic Taussig Cancer Institute

N. Callander

488 views
19:28

ASH 2024 Summary: Multiple Myeloma Highlights and Clinical Implicati…

2024 ASH Annual Meeting Insights Hub

S. Al Hadidi

485 views
26:59

Multiple Myeloma: A Journey From Pharaoh's Times to 2024

Houston Methodist

S. Ganguly

385 views
13:28

Debate: Using BCMA CAR-T in Early vs Late Line R/R MM Treatment

Louisville Hematology Highlights

K. Patel, S. Usmani

197 views
08:58

New

Transition of Care for Bispecific Antibodies in RRMM: Closing the Ga…

Cleveland Clinic Taussig Cancer Institute

S. Mazzoni

114 views
11:20

Real-World Characteristics and Outcomes in Patients With RRMM Receiv…

Adeel Khan

152 views
11:17

CAR-T Strategies and Clinical Considerations for R/R MM

Moffitt Cancer Center

K. Patel

163 views
29:37

Making Sense in R/R Myeloma: Guideline-Based Current Approaches

Saurabh Chhabra

193 views
17:52

2024 Updates on Emerging & Current Treatment of Multiple Myeloma

Indy Hematology Review

K. Anderson

1.3K views
16:55

Anti-BMCA Bispecific Antibodies - Independent Symposium at the 10th …

Springer Healthcare IME

S. Usmani

228 views
35:27

Advances in Multiple Myeloma 2024: From Bench to Bedside

Dana-Farber Cancer Institute

K. Anderson

732 views
05:55

ASH 2024 Insights: Efficacy of Anti-BCMA CAR-T in Myeloma Patients P…

2024 ASH Annual Meeting Insights Hub

J. Waldschmidt

157 views
24:35

ASCO® 2024 Summary: "The Best of Myeloma - Review of the Top 5 Abstr…

2024 ASCO® Annual Meeting Insights Hub

H. Hashmi

661 views
09:07

CARTITUDE-4 Update: OS With Cilta-Cel vs. SOC in Len-Refractory Mult…

Maria-Victoria Mateos

247 views
21:41

Multiple Myeloma: Hot Topics in 2024

Yale Cancer Center

S. Browning

232 views
10:57

Indefinite Treatment of Multiple Myeloma: Strategies for Frail Patie…

Shaji Kumar

129 views
12:37

Evaluating Infection Risk in CAR T-Cell Therapy and Bispecific Antib…

Meera Mohan

185 views
09:06

Talquetamab as a Bridging Therapy to BCMA CAR-T in RRMM

2024 ASH Annual Meeting Insights Hub

B. Dhakal

156 views
28:20

Expert Roundtable: Practical Approaches to Optimizing Care in Heavil…

MyCancerHaven

R. Vij, C. Costello, A. Abdallah, C. Gasparetto, G. Kaur, J. Berdeja

104 views
AUTOPLAY